Cord Blood Infusion
Cord Blood Infusion is a biological therapy with 9 clinical trials. Currently 1 active trials ongoing. Historical success rate of 80.0%.
Success Metrics
Based on 4 completed trials
Phase Distribution
Phase Distribution
5
Early Stage
1
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
57.1%
4 of 7 finished
42.9%
3 ended early
1
trials recruiting
9
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Expanded Access Protocol: Umbilical Cord Blood Infusions for Children With Brain Injuries
Umbilical Cord Blood Transplantation From Unrelated Donors
Safety and Effectiveness of Cord Blood Stem Cell Infusion for the Treatment of Cerebral Palsy in Children
Cord Blood Infusion for Children With Autism Spectrum Disorder
Cord Blood Expansion on Mesenchymal Stem Cells
Clinical Trials (9)
Expanded Access Protocol: Umbilical Cord Blood Infusions for Children With Brain Injuries
Umbilical Cord Blood Transplantation From Unrelated Donors
Safety and Effectiveness of Cord Blood Stem Cell Infusion for the Treatment of Cerebral Palsy in Children
Cord Blood Infusion for Children With Autism Spectrum Disorder
Cord Blood Expansion on Mesenchymal Stem Cells
Infusion of Allogeneic Umbilical Cord Blood-Derived Cluster of Differentiation Antigen 19 (CD19)-Specific T Cells
Cord Blood Fucosylation to Enhance Homing and Engraftment in Patients With Hematologic Malignancies
Intraosseous Infusion of Unrelated Cord Blood Grafts
Infusion of Expanded Cord Blood T Cells
All 9 trials loaded
Drug Details
- Intervention Type
- BIOLOGICAL
- Total Trials
- 9